HomeGLMD • NASDAQ
add
Galmed Pharmaceuticals Ltd
Previous close
$0.51
Day range
$0.49 - $0.55
Year range
$0.41 - $2.67
Market cap
3.56M USD
Avg Volume
36.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.04M | 85.04% |
Net income | -4.82M | -50.14% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.02M | -83.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.16M | 18.43% |
Total assets | 18.63M | 0.69% |
Total liabilities | 2.84M | 30.92% |
Total equity | 15.78M | — |
Shares outstanding | 6.58M | — |
Price to book | 0.21 | — |
Return on assets | -37.83% | — |
Return on capital | -43.59% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.82M | -50.14% |
Cash from operations | -1.94M | 1.22% |
Cash from investing | 1.43M | 140.24% |
Cash from financing | 1.19M | 165.18% |
Net change in cash | 671.00K | 113.23% |
Free cash flow | -1.99M | -5.77% |
About
Founded
2000
Website
Employees
5
